Xianbin Yu

4PUBLICATIONS
53CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Speech recognition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 06, 2025
Radiotherapy induces YTHDF2 in dendritic cells impairing cross-presentation and T cell function.

Dapeng Chen, Liangliang Wang, Chuangyu Wen

|May 01, 2024
Targeting the Dendritic Cell-Secreted Immunoregulatory Cytokine CCL22 Alleviates Radioresistance.

Jason Bugno, Liangliang Wang, Xianbin Yu

|Jan 27, 2023
Exon architecture controls mRNA m<sup>6</sup>A suppression and gene expression.

P Cody He, Jiangbo Wei, Xiaoyang Dou

|May 05, 2022
FTO mediates LINE1 m<sup>6</sup>A demethylation and chromatin regulation in mESCs and mouse development.

Jiangbo Wei, Xianbin Yu, Lei Yang

Pageof 1